Compounding Tamiflu suspension and Relenza is leading to problems

Compounding Tamiflu suspension and Relenza is leading to problems.

Antivirals are recommended to treat influenza in children under age 5 since they're at high risk for flu complications.

But there's a shortage of commercial Tamiflu suspension as Roche focuses on making the capsules since they're faster to produce.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote